The saliva-based testing/screening market was estimated to be US$ 349.3 Million in 2022.
The saliva-based testing/screening market is expected grow at a CAGR of 8.3% between 2023 to 2032.
The global saliva-based testing/screening market is being driven by several factors, including the increasing prevalence of infectious and chronic diseases, growing demand for non-invasive and rapid diagnostic tests, and the need for convenient and scalable testing solutions due to the COVID-19 pandemic.
The saliva collection kits/devices segment is to be the largest as it forms the basis for all saliva-based testing. The demand for saliva collection kits/devices is expected to remain high across various application areas, including infectious diseases, cancer, and genetic testing.
Asia-Pacific is a rapidly growing market for the saliva-based testing/screening market, with a large and rapidly growing population driving demand for improved healthcare infrastructure and diagnostic technologies.
Academic and research institutes segment is the fastest-growing segment. Academic and research institutes play a critical role in the development and validation of new diagnostic technologies, including saliva-based tests.
BioChain Institute Inc., Biosynex SA, Cell Projects Ltd., Chembio Diagnostics, Inc., Creative Diagnostics, DNA Genotek Inc., Hologic, Invitek Molecular GmbH, Kyodo International, Inc., Mawi DNA Technologies LLC, NEOGEN Corporation, OraSure Technologies, Qiagen, Salimetrics, LLC., Sedia Biosciences Corporation, Spectrum Solutions, Thermo Fisher Scientific, Xiamen Zeesan Biotech Co., Ltd., Zymo Research Corporation among others, are the prominent players in this market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved